CEOs: Orthopedic implant demand to rebound with economy

Demand for orthopedic implants will remain under pressure until the economy improves and consumers have insurance again, Zimmer Holdings Chief Executive David Dvorak said at the J.P. Morgan Healthcare Conference in San Francisco. "There will continue to be an impact until unemployment rates are reduced and (insurance) enrollment rates go back up," Dvorak told investors in a presentation webcast. Report

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.